These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 28340200

  • 1. Cytokines profile in immunocompetent mice during Trichosporon asahii infection.
    Montoya AM, González GM, Martinez-Castilla AM, Aguilar SA, Franco-Molina MA, Coronado-Cerda E, Rosas-Taraco AG.
    Med Mycol; 2018 Jan 01; 56(1):103-109. PubMed ID: 28340200
    [Abstract] [Full Text] [Related]

  • 2. In vivo pathogenicity of Trichosporon asahii isolates with different in vitro enzymatic profiles in an immunocompetent murine model of systemic trichosporonosis.
    Montoya AM, Luna-Rodríguez CE, Treviño-Rangel RJ, Becerril-García M, Ballesteros-Elizondo RG, Saucedo-Cárdenas O, González GM.
    Med Mycol; 2018 Jun 01; 56(4):434-441. PubMed ID: 28992352
    [Abstract] [Full Text] [Related]

  • 3. Effects of macrophage colony-stimulating factor (M-CSF) on anti-fungal activity of mononuclear phagocytes against Trichosporon asahii.
    Sasaki E, Tashiro T, Kuroki M, Seki M, Miyazaki Y, Maesaki S, Tomono K, Kadota J, Kohno S.
    Clin Exp Immunol; 2000 Feb 01; 119(2):293-8. PubMed ID: 10632665
    [Abstract] [Full Text] [Related]

  • 4. Pathogenicity of Trichosporon asahii in a murine model of disseminated trichosporonosis.
    Yang RY, Wang WL, Ao JH, Hao ZF, Zhang J, Wang CM.
    Chin Med J (Engl); 2008 Dec 20; 121(24):2557-60. PubMed ID: 19187595
    [Abstract] [Full Text] [Related]

  • 5. Early transcriptional response of human monocyte-like THP-1 cells in response to Trichosporon asahii infection.
    Cong L, Liao Y, Lu X, Xia Z, Li H, Yang R.
    Mycopathologia; 2015 Feb 20; 179(1-2):11-20. PubMed ID: 25179349
    [Abstract] [Full Text] [Related]

  • 6. Antifungal Activity and Potential Action Mechanism of Allicin against Trichosporon asahii.
    Yang X, Bai S, Wu J, Fan Y, Zou Y, Xia Z, Ao J, Chen T, Zhang M, Yang R.
    Microbiol Spectr; 2023 Jun 15; 11(3):e0090723. PubMed ID: 37199655
    [Abstract] [Full Text] [Related]

  • 7. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
    Mariné M, Bom VL, de Castro PA, Winkelstroter LK, Ramalho LN, Brown NA, Goldman GH.
    Virulence; 2015 Jun 15; 6(5):476-86. PubMed ID: 25751127
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Trichosporon asahii sepsis in a patient with pediatric malignancy.
    Ozkaya-Parlakay A, Karadag-Oncel E, Cengiz AB, Kara A, Yigit A, Gucer S, Gur D.
    J Microbiol Immunol Infect; 2016 Feb 15; 49(1):146-9. PubMed ID: 23419599
    [Abstract] [Full Text] [Related]

  • 10. Complicated Trichosporon asahii mastoiditis in immunocompetent child.
    Al Momani M, Yusef DH, Hamasha D, Hamad MRA, Farran S.
    BMC Infect Dis; 2021 Dec 07; 21(1):1229. PubMed ID: 34876058
    [Abstract] [Full Text] [Related]

  • 11. Development of a loop-mediated isothermal amplification assay for rapid detection of Trichosporon asahii in experimental and clinical samples.
    Zhou J, Liao Y, Li H, Lu X, Han X, Tian Y, Chen S, Yang R.
    Biomed Res Int; 2015 Dec 07; 2015():732573. PubMed ID: 25692144
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic efficacy of posaconazole in a murine model of disseminated trichosporonosis.
    Treviño-Rangel Rde J, López LJ, Palma-Nicolás JP, Hernández-Bello R, González JG, González GM.
    J Antimicrob Chemother; 2014 Apr 07; 69(4):1075-8. PubMed ID: 24252752
    [Abstract] [Full Text] [Related]

  • 13. [Pathogenesis of Trichosporon asahii and strategies for infectious control of disseminated trichosporonosis].
    Tokimatsu I, Karashima R, Yamagata E, Yamakami Y, Nagai H, Kadota J, Nasu M.
    Nihon Ishinkin Gakkai Zasshi; 2003 Apr 07; 44(3):181-6. PubMed ID: 12913806
    [Abstract] [Full Text] [Related]

  • 14. Pathogenicity of phospholipase B1 of Trichosporon asahii in immunosuppressed mice.
    Cheng X, Zhu H, Bai S, Zou Y, Xia Z, Yang R.
    Mycoses; 2023 Jun 07; 66(6):467-476. PubMed ID: 36680377
    [Abstract] [Full Text] [Related]

  • 15. [Fungemia due to Trichosporon asahii in a patient with hematological malignancy].
    Odero V, Galán-Sánchez F, García-Agudo L, García-Tapia AM, Guerrero-Lozano I, Rodríguez-Iglesias MA.
    Rev Iberoam Micol; 2015 Jun 07; 32(1):59-61. PubMed ID: 24071639
    [Abstract] [Full Text] [Related]

  • 16. Epidemiological study of Trichosporon asahii infections over the past 23 years.
    Li H, Guo M, Wang C, Li Y, Fernandez AM, Ferraro TN, Yang R, Chen Y.
    Epidemiol Infect; 2020 Jul 24; 148():e169. PubMed ID: 32703332
    [Abstract] [Full Text] [Related]

  • 17. Experimental model of progressive disseminated trichosporonosis in mice with latent trichosporonemia.
    Yamagata E, Kamberi P, Yamakami Y, Hashimoto A, Nasu M.
    J Clin Microbiol; 2000 Sep 24; 38(9):3260-6. PubMed ID: 10970368
    [Abstract] [Full Text] [Related]

  • 18. Disseminated trichosporonosis due to Trichosporon asahii in a diabetic patient.
    Negi V, Sharma M, Juyal D, Kotian S, Sharma N.
    Indian J Pathol Microbiol; 2015 Sep 24; 58(2):246-8. PubMed ID: 25885147
    [Abstract] [Full Text] [Related]

  • 19. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan.
    Ruan SY, Chien JY, Hsueh PR.
    Clin Infect Dis; 2009 Jul 01; 49(1):e11-7. PubMed ID: 19489711
    [Abstract] [Full Text] [Related]

  • 20. [An overview on Trichosporon asahii and its infections].
    Hazırolan G.
    Mikrobiyol Bul; 2012 Oct 01; 46(4):707-15. PubMed ID: 23188586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.